tiprankstipranks
ELEVAI Labs Inc. (ELAB)
NASDAQ:ELAB
US Market

ELEVAI Labs Inc. (ELAB) Stock Price & Analysis

23 Followers

ELAB Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.48 - $4.24
Previous Close$0.5
Volume30.42K
Average Volume (3M)167.70K
Market Cap
$9.44M
Enterprise Value$9.65M
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$210.49K
Price to Earnings (P/E)
Beta0.57
May 15, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding18,892,115
10 Day Avg. Volume88,699
30 Day Avg. Volume167,703
Standard Deviation0.26
R-Squared0.00385
Alpha-0.16
Financial Highlights & Ratios
Price to Book (P/B)164.24
Price to Sales (P/S)6.40
Price to Cash Flow (P/CF)-3.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit8.51
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Ownership Overview

10.42%0.00%0.28%89.31%
10.42% Insiders
0.28% Other Institutional Investors
89.31% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

ELAB FAQ

What was ELEVAI Labs Inc.’s price range in the past 12 months?
ELEVAI Labs Inc. lowest stock price was $0.48 and its highest was $4.24 in the past 12 months.
    What is ELEVAI Labs Inc.’s market cap?
    Currently, no data Available
    When is ELEVAI Labs Inc.’s upcoming earnings report date?
    ELEVAI Labs Inc.’s upcoming earnings report date is May 15, 2024 which is 68 days ago.
      How were ELEVAI Labs Inc.’s earnings last quarter?
      ELEVAI Labs Inc. released its earnings results on Mar 29, 2024. The company reported -$0.067 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.067.
        Is ELEVAI Labs Inc. overvalued?
        According to Wall Street analysts ELEVAI Labs Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does ELEVAI Labs Inc. pay dividends?
          ELEVAI Labs Inc. does not currently pay dividends.
          What is ELEVAI Labs Inc.’s EPS estimate?
          ELEVAI Labs Inc.’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does ELEVAI Labs Inc. have?
          ELEVAI Labs Inc. has 18,892,115 shares outstanding.
            What happened to ELEVAI Labs Inc.’s price movement after its last earnings report?
            ELEVAI Labs Inc. reported an EPS of -$0.067 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 3.175%.
              Which hedge fund is a major shareholder of ELEVAI Labs Inc.?
              Currently, no hedge funds are holding shares in ELAB
              ---

              ELEVAI Labs Inc. Stock Smart Score

              10
              Unlock Smart Score
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Company Description

              ELEVAI Labs Inc.

              Elevai Labs, Inc., a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc. and changed its name to Elevai Labs, Inc. in December 2021. Elevai Labs, Inc. was incorporated in 2020 and is based in Newport Beach, California.
              ---
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis